Cargando…

Chemoprevention: beyond tamoxifen

Detalles Bibliográficos
Autor principal:	Cuzick, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231899/ http://dx.doi.org/10.1186/bcr1219

Ejemplares similares

Breast cancer chemoprevention: beyond tamoxifen
por: Fabian, Carol J
Publicado: (2001)

Chemoprevention for breast cancer: current status
por: Boyle, P
Publicado: (2004)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
por: Klijn, JGM, et al.
Publicado: (2005)

A case–control study to estimate the impact on breast cancer death of the breast screening programme in Wales
por: Fielder, HM, et al.
Publicado: (2004)

Beyond insulin: rethinking cellular metabolism
por: Thompson, Craig B
Publicado: (2012)

Metabolism and metastasis: in the bone marrow and beyond
por: Dias, Sérgio
Publicado: (2010)

Imaging tumour response: beyond RECIST
por: Koh, Dow-Mu
Publicado: (2014)

Chemoprevention in oral leukoplakia: challenges and current landscape
por: Palma, Victor de Mello, et al.
Publicado: (2023)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Beyond the image : sense and non-sense in imaging biomarkers
por: Oudkerk, Matthijs
Publicado: (2014)

Prioritisation of specialist health care services: going beyond the evidence
por: Webb, Philip, et al.
Publicado: (2014)

How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013)

Eating disorders in young males: moving beyond stereotype and stigma
por: Shu, Chloe, et al.
Publicado: (2014)

Beyond descriptor vectors: QSAR modelling using structural similarity
por: Zell, Andreas, et al.
Publicado: (2008)

Estimating the Risks and Benefits of Tamoxifen for Prophylactic Breast Cancer Chemoprevention in Korea
por: Kim, Dong Uk, et al.
Publicado: (2012)

Selecting women for breast cancer chemoprevention and what agents should be used
por: Cuzick, J
Publicado: (2012)

P276 Molecular epidemiology of clinical filamentous fungi in Qatar beyond Aspergillus and Fusarium
por: Mohamed, Husam Eldin, et al.
Publicado: (2022)

High efficiency coronary MRA with non-rigid cardiac motion correction: beyond the quiescent period
por: Pang, Jianing, et al.
Publicado: (2016)

O029 Predictors of acute insomnia during the COVID-19 pandemic beyond perceived stress
por: Meaklim, H, et al.
Publicado: (2021)

Beyond the FANTOM4
por: Suzuki, Harukazu, et al.
Publicado: (2010)

Beyond total treatment effects in RCTs: why we need to measure outcomes at baseline when investigating mediation
por: Landau, Sabine, et al.
Publicado: (2015)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Cardiovascular magnetic resonance with late gadolinium enhancement improves mortality prediction beyond echocardiography: a comparative effectiveness study
por: Schelbert, Erik B, et al.
Publicado: (2012)

Beyond late gadolinium enhancement: the key role of diffuse myocardial fibrosis in severe aortic stenosis - an Equilibrium Contrast CMR study
por: Flett, Andrew S, et al.
Publicado: (2011)

A family carrying a homozygous LACC1 truncated mutation expands the clinical phenotype of this disease beyond systemic-onset juvenile idiopathic arthritis
por: Arostegui, JI, et al.
Publicado: (2015)

Quantitative of myocardial extracellular volume fraction improves characterization of fibrotic burden in patients with apical hypertrophic cardiomyopathy beyond visual assessment with late gadolinium enhancement
por: Watanabe, Eri, et al.
Publicado: (2012)

Disproportionate abdominal visceral fat mass reduction and complete reversal of cardiovascular remodelling accompany Roux-en-Y gastric bypass but not gastric banding - benefits beyond simply weight loss
por: Rayner, Jennifer J, et al.
Publicado: (2016)

Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan
por: Kondo, M, et al.
Publicado: (2009)

Exploring the potential of dietary factors and plant extracts as chemopreventive agents in oral squamous cell carcinoma treatment
por: Kumar, Madhav, et al.
Publicado: (2023)

Chemoprevention of N‐Nitroso‐N‐methylurea‐induced Rat Mammary Cancer by Miso and Tamoxifen, Alone and in Combination
por: Gotoh, Takahiko, et al.
Publicado: (1998)

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen
por: Bychkovsky, Brittany, et al.
Publicado: (2022)

Beyond the genome (BTG) is a (PGDB) pathway genome database: HumanCyc
por: Trupp, Miles, et al.
Publicado: (2010)

Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?
por: Cuzick, J, et al.
Publicado: (2006)

Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment
por: Campbell, Aideen M, et al.
Publicado: (2018)

Adherence to hormone therapy in a chemoprevention randomised trial
por: Atkins, L, et al.
Publicado: (2008)

O26 More than meets the eye … When inflammation extends beyond the anterior chamber
por: Foley, Charlene, et al.
Publicado: (2021)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.
por: Decensi, A., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_c535rat27va39tv8oc3hldmg6d